Watchlist Price Alert

Lineage Cell Therapeutics... (LCTX)

AMEX: LCTX · Real-Time Price · USD

0.66

0.00 (0.27%)

At close: Jun 05, 2025, 3:59 PM

undefined

undefined%

After-hours: undefined

Lineage Cell Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-18.61M	-21.49M	-26.35M	-43.27M	-20.68M	-11.83M	-46.78M	-23.29M	18.62M
Depreciation & Amortization	609K	692K	727K	873K	2.04M	3M	3.27M	3.3M	4.76M
Stock-Based Compensation	5.08M	4.64M	4.29M	3.52M	2.23M	3.58M	5.4M	3.93M	7.95M
Other Working Capital	-7.19M	-8.06M	-12.94M	394K	1.09M	-2.42M	-630K	49K	-639K
Other Non-Cash Items	-1.4M	195K	3.73M	202K	-3.47M	-17.34M	6.93M	640K	-68.4M
Deferred Income Tax	n/a	-1.8M	n/a	-6M	-1.24M	-7.41M	-346K	-17.57M	-4.52M
Change in Working Capital	-8.77M	-10.8M	18.67M	21.11M	1.37M	-1.96M	638K	2.48M	-741K
Operating Cash Flow	-23.09M	-28.57M	1.06M	-23.56M	-19.75M	-31.95M	-30.88M	-30.52M	-42.33M
Capital Expenditures	-565K	-674K	-413K	-354K	-64K	-440K	-3.29M	-1.33M	-2.53M
Cash Acquisitions	n/a	n/a	45.75M	10.09M	13.06M	17.33M	15.11M	-8.9M	-8.38M
Purchase of Investments	-8.76M	-16.4M	-53.41M	6.02M	4.56M	-14.21M	-8K	-189K	-748K
Sales Maturities Of Investments	7.02M	63.53M	7.67M	-6.02M	-4.56M	14.21M	24.82M	n/a	748K
Other Investing Acitivies	-565K	n/a	-45.75M	14K	41K	65K	-8K	188K	13K
Investing Cash Flow	-2.31M	46.45M	-46.16M	9.74M	13.04M	16.96M	11.82M	-10.22M	-10.89M
Debt Repayment	-54K	-54K	-32K	-20K	-26K	-100K	-349K	172K	1.61M
Common Stock Repurchased	-23K	-37K	-17K	-54K	-27K	-110K	-241K	-888K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-182K	-34.41M	n/a	n/a
Other Financial Acitivies	-23K	-37K	1.53M	6.14M	24.79M	1.01M	35.77M	-3.57M	324K
Financial Cash Flow	35.86M	6.42M	1.63M	36.93M	29.86M	617K	5.77M	55.39M	32.78M
Net Cash Flow	10.36M	24.06M	-44.34M	23.09M	23.09M	-14.3M	-13.29M	14.75M	-20.14M
Free Cash Flow	-23.66M	-29.24M	646K	-23.91M	-19.82M	-32.39M	-34.17M	-31.84M	-44.85M